Literature DB >> 29935758

Musculoskeletal pain in early adolescence: A longitudinal examination of pain prevalence and the role of peer-related stress, worry, and gender.

Matilda Wurm1, Malin Anniko2, Maria Tillfors3, Ida Flink2, Katja Boersma2.   

Abstract

OBJECTIVE: Adolescence is a time of change during which several health problems, such as pain problems, increase. Psychosocial mechanisms involved in this development, such as interpersonal stressors and worry, are still understudied, especially longitudinally. The first aim of this study was to investigate the prevalence of musculoskeletal pain in Swedish adolescents between the ages 13 and 15 using pain grades. The second aim was to study the role of peer-related stress, worry, and gender in the development of musculoskeletal pain problems over time.
METHODS: Adolescents in 18 public schools were followed from 7th to 9th grade (N = 1181) and answered self-report questionnaires at three time points. Prevalence was assessed at all three time points and a moderated mediation analysis investigated if peer-related stress in 7th grade predicted musculoskeletal pain two years later and if this relationship was mediated by worry in 8th grade. Gender was entered as a moderator.
RESULTS: In 7th grade, 8.4% of adolescents reported musculoskeletal pain with some functional impairment. In 8th and 9th grade around 10% of adolescents reported musculoskeletal pain problems, with girls reporting a higher prevalence than boys. Peer-related stress in 7th grade predicted musculoskeletal pain problems in 9th grade, mediated by worry in 8th grade. The mediation was moderated by gender: peer-related stress predicted worry for girls, but not for boys.
CONCLUSION: Peer-related stress and worry seem to be involved in the development of pain over time. These factors should therefore be targeted in preventative interventions and during treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29935758     DOI: 10.1016/j.jpsychores.2018.05.016

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Worse health status, sleeping problems, and anxiety in 16-year-old students are associated with chronic musculoskeletal pain at three-year follow-up.

Authors:  Julia S Malmborg; Ann Bremander; M Charlotte Olsson; Anna-Carin Bergman; A Sofia Brorsson; Stefan Bergman
Journal:  BMC Public Health       Date:  2019-11-27       Impact factor: 3.295

2.  A widening gap between boys and girls in musculoskeletal complaints, while growing up from age 11 to age 20 - the PIAMA birth Cohort study.

Authors:  H Susan J Picavet; Ulrike Gehring; Amanda van Haselen; Gerard H Koppelman; Elise M van de Putte; Sarah Vader; J Hans C van der Wouden; Ruben J H Schmits; Henriette A Smit; Alet Wijga
Journal:  Eur J Pain       Date:  2021-01-29       Impact factor: 3.931

3.  Low social acceptance among peers increases the risk of persistent musculoskeletal pain in adolescents. Prospective data from the Fit Futures Study.

Authors:  Henriette Jahre; Margreth Grotle; Kaja Smedbråten; Kåre Rønn Richardsen; Pierre Côté; Ólöf Anna Steingrímsdóttir; Christopher Nielsen; Kjersti Storheim; Milada Småstuen; Synne Øien Stensland; Britt Elin Øiestad
Journal:  BMC Musculoskelet Disord       Date:  2022-01-13       Impact factor: 2.362

4.  Sleep phase and pre-sleep arousal predicted co-developmental trajectories of pain and insomnia within adolescence.

Authors:  Tor Arnison; Martien G S Schrooten; Serena Bauducco; Markus Jansson-Fröjmark; Jonas Persson
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

5.  Risk factors and risk profiles for neck pain in young adults: Prospective analyses from adolescence to young adulthood-The North-Trøndelag Health Study.

Authors:  Henriette Jahre; Margreth Grotle; Milada Småstuen; Maren Hjelle Guddal; Kaja Smedbråten; Kåre Rønn Richardsen; Synne Stensland; Kjersti Storheim; Britt Elin Øiestad
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.